1 / 10

Technical Briefing Seminar for PSM Consultants for HIV/AIDS, TB and Malaria PRIVATE SECTOR ART PROVIDER NETWORK IN KENYA

Technical Briefing Seminar for PSM Consultants for HIV/AIDS, TB and Malaria PRIVATE SECTOR ART PROVIDER NETWORK IN KENYA. INITIATIVE OF FHI/KMA Presented by Charles W. Abondo 01/2/2006. Background. FHI Institute for HIV/AIDS:

yaron
Download Presentation

Technical Briefing Seminar for PSM Consultants for HIV/AIDS, TB and Malaria PRIVATE SECTOR ART PROVIDER NETWORK IN KENYA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Technical Briefing Seminar for PSM Consultants for HIV/AIDS, TB and MalariaPRIVATE SECTOR ART PROVIDER NETWORK INKENYA INITIATIVE OF FHI/KMA Presented by Charles W. Abondo 01/2/2006

  2. Background • FHI Institute for HIV/AIDS: • Primary cooperative agency of USAID for ART delivery in Kenya under PEPFAR • Helped establish 28 public comprehensive care centres • Attention focused on upgrading CCC in public sector for PLWHAs

  3. LESSON LEARNED FROM PUBLIC SECTOR INITIATIVE • Comprehensive network approach to care for PLWHAs the way forward • Training all members of the care team in HIV/AIDS care and ART services vs specialized training for clinicians • Development of comprehensive HIV/AIDS curriculum vs focusing on ART treatment regimens • Partnership with the government to create a sense of ownership

  4. MAJOR CHALLENGES • Government procurement and supply system still inconsistent and full of leakages • Government overwhelmed by those seeking HIV/AIDS care • Expensive ARVs, counterfeits and unregistered drugs in the private sector • Quality of laboratory services suspect and expensive in the private sector • Few private pharmacies stock ARVs because of: • government subsidy • Fear of expiry • Inadequate training of private providers on HIV/AIDS care and ART services

  5. GOAL To expand access to comprehensive and quality HIV care and antieritroviral therapy services in the private sector based on a franchised care model and delivered through networks of accredited providers and technical support partners.

  6. Objectives • Strengthen the workplaces ART program • Establish a training and quality assurance system for private providers that conform to MOH requirements • Establish quality laboratory testing capacity that private partners can access • Support HMOs to provide ART services to their clients • Establish a network support centre

  7. Where are we? • Sub agreement with KMA/NASCOP signed • Logo for the network developed • Curriculum with core modules and CME modules developed • Selection of trainers, private practitioners, laboratories, and pharmacies completed • All SOPs ready • PSM system in place ( supplier contracted) • Network centre established • Counseling and support centres established

  8. Franchise Benefits • Training and opportunities for CMEs for medical practitioners • Sustained access to quality low cost ARVs and lab services • Access to specific government labs • Access to network support centres • Access to counseling and support centres • Participation of HMOs by providing cover • Access to government CCC for practicum

  9. new patients existing patient OI drugs & tests malaria quick-tests, ACT, cipro, penicillin, nystatin etc. HIV test counseling Management of OIs, CPT, IPT test (CD4/8) ARVs Initiation of ART counseling/support ARVs ARV resupply & management of care test CD4/8 & viral load counseling/support Steps in initiating care Entry Treatment Pharma Labs

  10. THE BEST WAY TO PREDICT THE FUTURE IS TO CREATE IT Peter Ducker

More Related